Status:
UNKNOWN
The Effect of Acupuncture Protocol Involving in Weizhong (BL4) and Huantiao (GB30) Points in Treating Ankylosing Spondylitis
Lead Sponsor:
Chengdu PLA General Hospital
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the effect of acupuncture protocol involving in Weizhong (BL4) and Huantiao (GB30) points in treating ankylosing spondylitis.
Eligibility Criteria
Inclusion
- Eligible adult (≥18 years of age) patients
- had a diagnosis of AS for at least 3 months defined as definite by the 1984 modified New York criteria
- Eligible patients also had a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) of ≥4 (0-10 cm scale)
- A visual analogue scale (VAS) score for total back pain of ≥4 (0-10 cm scale)
Exclusion
- Had received prior Acupuncture therapy
- With complete ankylosis of the spine, defined as the presence of bridging syndesmophytes at all intervertebral levels of the cervical and lumbar spine on lateral view spinal radiographs
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02260310
Start Date
October 1 2014
End Date
January 1 2018
Last Update
April 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
270 Rongdu street, Jin-niu district,Rheumatology Center of Integrated Medicine, General Hospital of Chengdu Military Area Command PLA，
Chengdu, Sichuan, China, 610083